How Much Weight Per Week Should You Lose on Zepbound?

Last reviewed: June 28, 2026

Last updated: June 28, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Tirzepatide, available as the brand-name Zepbound and through compounded formulations, has demonstrated significant weight loss results in clinical trials. Most patients experience 1 to 2 pounds of weekly weight loss initially, though this rate typically slows as treatment progresses and your body reaches a new equilibrium. Understanding realistic expectations helps you stay motivated and recognize whether your individual response aligns with clinical norms.

Typical Weekly Weight Loss Rate on Tirzepatide

Clinical trials of tirzepatide showed an average weight loss of approximately 22% of body weight over 72 weeks at the highest maintenance dose—roughly 1 to 2 pounds per week in the early treatment phase. This rate is significantly higher than other GLP-1 receptor agonists alone. The SURMOUNT trials, which evaluated Zepbound, documented consistent results across diverse patient populations, confirming that tirzepatide's dual GLP-1 and GIP receptor action produces more rapid initial weight reduction.

However, weekly loss is not linear. Most patients see faster results in weeks 1–12, then experience a natural slowdown as their metabolism adapts and appetite suppression reaches a steady state. By month 4 and beyond, many people plateau temporarily or lose at a slower rate of 0.5 to 1 pound per week. This is normal physiology, not treatment failure, and weight loss often resumes after dose adjustments or lifestyle reinforcement.

Why Individual Results Vary So Much

Genetic factors play a crucial role in how your body responds to tirzepatide. Your GLP-1 receptor sensitivity, appetite regulation pathways, and metabolic rate are partly determined by inherited variants. PlexusDx's Precision Peptide Genetic Test identifies key variants—including GLP1R rs6923761, MC4R rs17782313, and FTO rs9939609—that predict how effectively tirzepatide will work for your specific biology. Patients with favorable genetic profiles often see faster, larger weight reductions than population averages.

Non-genetic factors also heavily influence weekly weight loss: starting body weight (heavier individuals typically lose more pounds per week initially), diet quality, physical activity, sleep duration, stress levels, and medication adherence all matter. Someone eating 1,200 calories daily while exercising 5 days a week will lose faster than someone eating 1,800 calories with minimal activity—regardless of medication. PlexusDx supports this personalization by helping you understand your genetic predispositions and adjusting your dose independently of cost.

How Dose Escalation Affects Weekly Loss

Tirzepatide is typically started at a low dose (0.25 mg or 2.5 mg for oral forms) and escalated every 4 weeks to minimize gastrointestinal side effects and allow your body to adapt. Each dose increase often triggers a renewed acceleration in weight loss for 2–4 weeks before a new plateau emerges. The maximum maintenance dose is 15 mg weekly (or 50 mg oral), and clinical data shows the steepest loss curves occur when patients reach their optimal therapeutic dose—usually 10–15 mg weekly.

PlexusDx prices tirzepatide at a flat monthly rate regardless of dose level, so your dose may go up as your doctor adjusts your treatment, but your price won't. This approach removes the financial barrier to finding your optimal therapeutic dose, allowing your clinician to prioritize efficacy and safety rather than cost considerations. Compounded tirzepatide injection starts at $249 per month across all dose levels, and oral tirzepatide starts at $299 per month.

When to Expect Results to Slow or Plateau

Weight-loss plateaus typically occur after 8–16 weeks of treatment, not because tirzepatide stops working, but because your body has reached a new metabolic balance at the current dose. At this point, increasing your dose (if you haven't reached the maximum), intensifying your diet adherence, or adding structured exercise often restarts the loss curve. Some patients experience a 2–4 week stall followed by a sudden 3–5 pound drop—your body's way of shedding stored water and fat in clusters rather than smoothly.

Long-term adherence matters most. Clinical trials show that people who remain on tirzepatide for 2+ years achieve cumulative weight losses of 25–35% of body weight, substantially better than diet alone or short-term use. If your weekly loss slows to 0.25–0.5 pounds per week around month 3–4, this is expected and not a reason to stop—your body is still losing fat, just more gradually as you approach your natural set point.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection starts at $249/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Is 1–2 pounds per week normal on Zepbound or tirzepatide?

Yes. Clinical trials consistently showed 1–2 pounds weekly during the first 4–12 weeks, with rates naturally slowing thereafter. Your individual rate depends on starting weight, genetics, diet, and dose level. PlexusDx helps identify your genetic response profile through the Precision Peptide Genetic Test to predict your likely trajectory.

What do the SURMOUNT clinical trials show about tirzepatide weight loss?

The SURMOUNT trials (which led to FDA approval of Zepbound) demonstrated approximately 22% average body weight loss at the highest maintenance dose over 72 weeks. Patients on tirzepatide lost significantly more weight than those on GLP-1 agonists alone, confirming the dual GLP-1/GIP mechanism's effectiveness.

Can I get tirzepatide at PlexusDx without insurance?

Yes. PlexusDx offers compounded tirzepatide injection starting at $249 per month (flat rate, no insurance required, no membership fee). Oral tirzepatide starts at $299 per month. Both are HSA/FSA eligible and available across all 50 states from licensed 503A compounding pharmacies.

What if my weight loss stalls or slows down?

Weight plateaus are expected after 8–16 weeks and don't mean the medication stopped working. Your doctor can increase your dose, reinforce dietary changes, or add exercise. Most people experience multiple cycles of loss and brief plateaus over months of treatment before reaching a new stable weight.

How does the Precision Peptide Genetic Test predict my weight loss response?

The Precision Peptide Genetic Test ($99 add-on after your first month) analyzes 14 metabolic pathways and 49 peptides, including GLP1R, GIPR, MC4R, and FTO variants that influence how effectively your body responds to tirzepatide. This helps your clinician optimize your dose and lifestyle plan for your unique biology.

Related Reading

• Can My Dna Tell Me How Do You Lose Weight
• Can A Dna Test Tell Me How Do You Lose Weight
• Can You Get A Dna Test To See How Do You Lose Weight
• Zepbound For Losing Weight

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.